Sponsor or institution

Clinical trials and research at Ao Generium

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• GNR-139 vs Eylea in nAMD: a head-to-head comparison

  This trial tests whether the biosimilar GNR-139 can match the effectiveness of Eylea in adults with neovascular age-related macular degeneration who have not yet received treatment.

  Recruiting at 2 sites Phase 3 Ao Generium · Cheboksary, Cheboksary and 13 other locations · NCT07844148

• GNR-097 gene therapy for Duchenne muscular dystrophy in boys

  This study tests a gene therapy (GNR-097) to see if it is safe, tolerable, and potentially beneficial for ambulatory boys with Duchenne muscular dystrophy.

  Recruiting at 6 sites Phase 1/2 Ao Generium · Minsk and 5 other locations · NCT07673809

Quick answers

How many clinical trials run by Ao Generium are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in Russia (2 trials), Belarus (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →